Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solon Eiendom ASA – Primary insider notification


Posted on: 21 Aug 18

(Oslo, Norway, September 19, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 20.000 shares in Solon Eiendom ASA at a price of NOK 28.9831.

Following this transaction Tore Aksel Voldberg through Skøien AS holds 8 758 398 shares and through Dukat AS holds 3 706 602 for a total holding of 12 465 000 shares, equalling 22,053 % of the total share capital and votes of the Company.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

Further information
Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
E-mail: am@soloneiendom.no Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
E-mail: sd@soloneiendom.no Cell Phone: +47 952 55 620

About Solon Eiendom
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region.

Attachment

GlobeNewswire
globenewswire.com

Last updated on: 20/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.